ArriVent BioPharma, Inc. - Common Stock (AVBP)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / Common Stock
Shares outstanding
41M
Number of holders
80
Total 13F shares, excl. options
28.5M
Shares change
+922K
Total reported value, excl. options
$757M
Value change
+$26.6M
Number of buys
52
Number of sells
-22
Price
$26.64

Significant Holders of ArriVent BioPharma, Inc. - Common Stock (AVBP) as of Q4 2024

92 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock as of Q4 2024.
ArriVent BioPharma, Inc. - Common Stock (AVBP) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28.5M shares of 41M outstanding shares and own 69.49% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (4.48M shares), ORBIMED ADVISORS LLC (3.03M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.25M shares), BlackRock, Inc. (2.14M shares), FMR LLC (2.1M shares), Octagon Capital Advisors LP (2.06M shares), Sofinnova Investments, Inc. (1.7M shares), INFINITUM ASSET MANAGEMENT, LLC (1.64M shares), Novo Holdings A/S (1.52M shares), and General Catalyst Group Management, LLC (1.49M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.